DekaBank Deutsche Girozentrale’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-45,000
| Closed | -$290K | – | 1414 |
|
|
2025
Q1 | $290K | Buy |
+45,000
| New | +$372K | ﹤0.01% | 1056 |
|
|
2024
Q2 | – | Sell |
-45,000
| Closed | -$214K | – | 1492 |
|
|
2024
Q1 | $214K | Hold |
45,000
| – | – | ﹤0.01% | 1146 |
|
|
2023
Q4 | $222K | Hold |
45,000
| – | – | ﹤0.01% | 1189 |
|
|
2023
Q3 | $322K | Buy |
+45,000
| New | +$360K | ﹤0.01% | 1106 |
|
|
2023
Q1 | – | Sell |
-23,900
| Closed | -$230K | – | 1343 |
|
|
2022
Q4 | $230K | Sell |
23,900
-1,950
| -8% | -$34.4K | ﹤0.01% | 1201 |
|
|
2022
Q3 | $476K | Hold |
25,850
| – | – | ﹤0.01% | 1057 |
|
|
2022
Q2 | $1.3M | Sell |
25,850
-13,745
| -35% | -$712K | ﹤0.01% | 818 |
|
|
2022
Q1 | $3M | Buy |
39,595
+3,627
| +10% | +$323K | 0.01% | 667 |
|
|
2021
Q4 | $5.46M | Sell |
35,968
-105
| -0.3% | -$18K | 0.01% | 546 |
|
|
2021
Q3 | $7.42M | Buy |
36,073
+6,432
| +22% | +$1.42M | 0.02% | 445 |
|
|
2021
Q2 | $6.2M | Buy |
29,641
+9,641
| +48% | +$1.77M | 0.02% | 472 |
|
|
2021
Q1 | $3.49M | Hold |
20,000
| – | – | 0.01% | 571 |
|
|
2020
Q4 | $2.39M | Buy |
+20,000
| New | +$2.13M | 0.01% | 630 |
|
|
2019
Q3 | – | Sell |
-10,110
| Closed | -$62K | – | 1085 |
|
|
2019
Q2 | $62K | Buy |
10,110
+3,955
| +64% | +$31.1K | ﹤0.01% | 1109 |
|
|
2019
Q1 | $185K | Buy |
6,155
+1,100
| +22% | +$34.7K | ﹤0.01% | 1048 |
|
|
2018
Q4 | $190K | Sell |
5,055
-1,100
| -18% | -$42.6K | ﹤0.01% | 974 |
|
|
2018
Q3 | $185K | Hold |
6,155
| – | – | ﹤0.01% | 1071 |
|
|
2018
Q2 | $165K | Hold |
6,155
| – | – | ﹤0.01% | 1066 |
|
|
2018
Q1 | $252K | Sell |
6,155
-125
| -2% | -$5.02K | ﹤0.01% | 962 |
|
|
2017
Q4 | $127K | Hold |
6,280
| – | – | ﹤0.01% | 972 |
|
|
2017
Q3 | $127K | Hold |
6,280
| – | – | ﹤0.01% | 978 |
|
|
2017
Q2 | $144K | Hold |
6,280
| – | – | ﹤0.01% | 946 |
|
|
2017
Q1 | $158K | Sell |
6,280
-525
| -8% | -$14.4K | ﹤0.01% | 861 |
|
|
2016
Q4 | $177K | Buy |
6,805
+525
| +8% | +$15.3K | ﹤0.01% | 847 |
|
|
2016
Q3 | $259K | Hold |
6,280
| – | – | ﹤0.01% | 783 |
|
|
2016
Q2 | $901K | Buy |
6,280
+475
| +8% | +$54.4K | 0.01% | 568 |
|
|
2016
Q1 | $597K | Sell |
5,805
-1,050
| -15% | -$113K | 0.01% | 625 |
|
|
2015
Q4 | $1.15M | Buy |
6,855
+100
| +1% | +$15.4K | 0.01% | 549 |
|
|
2015
Q3 | $955K | Buy |
6,755
+230
| +4% | +$51.6K | 0.01% | 559 |
|
|
2015
Q2 | $1.45M | Buy |
6,525
+925
| +17% | +$163K | 0.02% | 501 |
|
|
2015
Q1 | $926K | Sell |
5,600
-800
| -13% | -$130K | 0.01% | 584 |
|
|
2014
Q4 | $745K | Sell |
6,400
-575
| -8% | -$60.1K | 0.01% | 618 |
|
|
2014
Q3 | $582K | Buy |
6,975
+975
| +16% | +$88.1K | 0.01% | 623 |
|
|
2014
Q2 | $554K | Sell |
6,000
-150
| -2% | -$13.2K | 0.01% | 585 |
|
|
2014
Q1 | $557K | Buy |
6,150
+200
| +3% | +$22.3K | 0.01% | 556 |
|
|
2013
Q4 | $614K | Buy |
5,950
+1,265
| +27% | +$89.4K | 0.01% | 520 |
|
|
2013
Q3 | $296K | Buy |
+4,685
| New | +$264K | 0.01% | 606 |
|
Other funds holding NVAX
SCM
S
DekaBank Deutsche Girozentrale's NVAX Position: Q2 2025 in Review
DekaBank Deutsche Girozentrale sold out of Novavax (NVAX) in Q2 2025, closing a stake of 45,000 shares — an estimated $290K sold.
DekaBank Deutsche Girozentrale first reported a position in NVAX in Q3 2013 and held it in 37 quarters. The position peaked at $7.42M in Q3 2021. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.
- DekaBank Deutsche Girozentrale reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 45,000 Novavax shares in Q2 2025, an estimated $290K.
- DekaBank Deutsche Girozentrale first reported a position in Novavax in Q3 2013 and held it in 37 quarters.
- DekaBank Deutsche Girozentrale's Novavax position peaked at $7.42M in Q3 2021.
- 250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2025, filed 30 Jul 2025.